PAF Antagonists as Potential Therapeutic Agents in Cardiac Anaphylaxis and Myocardial Ischemia

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cardiovascular Drug Reviews

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1527-3466.1989.TB00526.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ginkgolide B protects isolated hearts against arrhythmias induced by ischemia but not reperfusion.

  1989cited by this paper
• Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog.

  1989cited by this paper
• Is there a case for PAF antagonists in the treatment of ischemic states?

  1989cited by this paper
• Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity.

  1988cited by this paper
• Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog.

  1988cited by this paper
• Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia.

  1988cited by this paper
• Natural antagonists of platelet‐activating factor

  1988cited by this paper
• Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.

  1988cited by this paper
• Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor.

  1988cited by this paper
• Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.

  1988cited by this paper
• Effects of BN 52063 and other agents inhibiting platelet‐activating factor‐induced contractile responses in rat portal vein

  1988cited by this paper
• The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites.

  1987cited by this paper
• The Coronary, Inotropic, Chronotropic and Arrhythmogenic Effects of Paf-Acether on Isolated Guinea-Pig Heart and their Selective Inhibition by BN 52021

  1987cited by this paper
• Perspectives in platelet-activating factor research.

  1987cited by this paper
• GINKGOLIDES: POTENT PLATELET ACTIVATING FACTOR ANTAGONISTS ISOLATED FROM GINKGO BILOBA L.: CHEMISTRY, PHARMACOLOGY AND CLINICAL APPLICATIONS

  1987cited by this paper
• Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion.

  1987cited by this paper
• THE EFFECT OF PREDNISOLONE, THROMBOXANE, AND PLATELET‐ACTIVATING FACTOR RECEPTOR ANTAGONISTS ON LYMPHOCYTE AND PLATELET MIGRATION IN EXPERIMENTAL CARDIAC TRANSPLANTATION

  1987cited by this paper
• Platelet-activating factor and cellular immune responses.

  1987cited by this paper
• Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study.

  1987cited by this paper
• Antagonism of vasoconstriction induced by platelet‐activating factor in guinea‐pig perfused hearts by selective platelet‐activating factor receptor antagonists

  1987cited by this paper
• Metabolic basis of increased vulnerability to fibrillation in myocardial ischaemia.

  1987cited by this paper
• Protective Effect of Verapamil on the Cardiac and Circulatory Alterations Induced by Platelet‐Activating Factor

  1987cited by this paper
• The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.

  1987cited by this paper
• Conformational Properties of the PAF-Acether Receptor on Platelets Based on Structure—Activity Studies

  1987cited by this paper
• Direct effects of platelet activating factor (PAF) on cardiac function in isolated guinea pig heart

  1987cited by this paper
• The anoxic rat-heart myocyte produces and releases platelet activating factor (PAF) as a component of its ischemia-like pathology

  1987cited by this paper
• Platelet‐Activating Factor and the Release of a Platelet‐Derived Coronary Artery Vasodilator Substance in the Canine

  1986cited by this paper
• Intravascular release of platelet-activating factor during atrial pacing.

  1986cited by this paper
• The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats.

  1986cited by this paper
• Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.

  1986cited by this paper
• Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4

  1986cited by this paper
• Effect of platelet-activating factor (PAF) on human cardiac muscle.

  1986cited by this paper
• Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.

  1986cited by this paper
• Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog.

  1986cited by this paper
• Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor.

  1986cited by this paper
• The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.

  1986cited by this paper
• Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine

  1986cited by this paper
• Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.

  1986cited by this paper
• Mechanisms of arrhythmogenesis during myocardial ischemia and reperfusion: a perspective of our current understanding.

  1986cited by this paper
• PAF-acether specific binding sites: 2. Design of specific antagonists

  1986cited by this paper
• PAF-acether specific binding sites: 1. quantitative SAR study of PAF-acether isosteres

  1986cited by this paper
• Is platelet activating factor (PAF) a mediator of endotoxin shock?

  1985cited by this paper
• Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

  1985cited by this paper
• Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.

  1985cited by this paper
• The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.

  1985cited by this paper
• Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles.

  1985cited by this paper
• Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.

  1985cited by this paper
• BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.

  1985cited by this paper
• Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.

  1984cited by this paper
• Reperfusion-induced arrhythmias: mechanisms and prevention.

  1984cited by this paper
• Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.

  1984cited by this paper
• Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.

  1984cited by this paper
• Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

  1983cited by this paper
• Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.

  1983cited by this paper
• Platelet-activating factor: an effector substance of the vasopermeability changes induced by the infusion of immune aggregates in the mouse.

  1983cited by this paper
• Evidence that two major replicons comprise the genome of Staphylococcus aureus.

  1967cited by this paper
• POTASSIUM CHLORIDE AND INTESTINAL ULCERATION.

  1965cited by this paper

• Progress in the Development of Platelet‐Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases

  2018cites this paper
• Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.

  2001cites this paper
• Role of platelet-activating factor in cardiovascular pathophysiology.

  2000cites this paper
• A platelet activating factor antagonist attenuates the effects of testicular ischemia.

  1997cites this paper
• Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.

  1997cites this paper
• PAF effects on eicosanoid release in neonatal rat cardiomyocytes.

  1995cites this paper
• Platelet-activating factor antagonists

  1995cites this paper
• Synthesis and antiaggregational activity relative to platelets of the analog of platelet activating factor — 2-acetoxybenzoic acid derivative

  1995cites this paper
• Cardiac ultrastructural effects of the platelet-activating factor and its antagonist BN 52021.

  1995cites this paper
• Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury.

  1995cites this paper
• Platelet-activating factor antagonists: scientific background and possible clinical applications.

  1994cites this paper
• Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.

  1994cites this paper
• Platelet-Activating Factor and Calcium Signaling: Its Implication in Cellular Responses

  1994cites this paper
• Effects of an extract of Ginkgo biloba On the action potential and associated transmembrane ionic currents in mammalian cardiac myocytes: Inhibition of isoproterenol‐induced chloride current

  1994cites this paper
• Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.

  1994cites this paper
• Platelet-Activating-Factor-Induced Changes in Cardiovascular Function and Oxyradical Status of Myocardium in Presence of the PAF Antagonist CV-6209

  1994cites this paper
• Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review.

  1993cites this paper
• Recent progress in ginkgolide research

  1991cites this paper
• Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.

  1991cites this paper